Atrogi begins human trials for weight loss and muscle retention

The Swedish biotech leads the first subjects in the new ATR-258 study and believes that the next breakthrough in obesity will be about muscle protection. Swedish Stage Clinical Biotechnology Atrogy The first subjects in a new human trial of ATR-258,…












